Pathogenesis, risk assessment and prevention of type 2 diabetes mellitus

Obesity Facts

Volumn 1, Issue 3, 2008, Pages 128-137

  Joost, Hans Georg ^a  

^a GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

Author keywords

Diabetes mellitus; Disease risk; Gene variants; Insulin resistance; Nutrition

Indexed keywords

BIOLOGICAL MARKER; CYTOKINE;

ADIPOSE TISSUE; ANIMAL; DIET; GENETIC PREDISPOSITION; HUMAN; INFLAMMATION; INSULIN RESISTANCE; LIFESTYLE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PANCREAS ISLET BETA CELL; PHENOTYPE; PHYSIOLOGY; REVIEW; RISK FACTOR;

ADIPOSE TISSUE; ANIMALS; BIOLOGICAL MARKERS; CYTOKINES; DIABETES MELLITUS, TYPE 2; DIET; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INFLAMMATION; INSULIN RESISTANCE; INSULIN-SECRETING CELLS; LIFE STYLE; OBESITY; PHENOTYPE; RISK FACTORS;

EID: 58149182392     PISSN: 16624025     EISSN: 16624033     Source Type: Journal    
DOI: 10.1159/000137673     Document Type: Review

References (92)

1. Diamond J: The double puzzle of diabetes. Nature 2003;423:599-602. (Pubitemid 36713209)
2. Hanefeld M, Kohler C: Screening, prevention and early therapy of type 2 diabetics MMW Fortschr Med 2004;146:28-31. (Pubitemid 39256316)
3. Wabitsch M, Hauner H, Hertrampf M, Muche R, Hay B, Mayer H, Kratzer W, Debatin KM, Heinze E: Type II diabetes mellitus and impaired glucose regulation in Caucasian children and adolescents with obesity living in Germany. Int J Obes Relat Metab Disord 2004;28:307-313. (Pubitemid 38223514)
4. Manuel DG, Schultz SE: Health-related quality of life and health-adjusted life expectancy of people with diabetes in Ontario, Canada, 1996-1997. Diabetes Care 2004;27:407-414. (Pubitemid 38174065)
5. Wolf AM, Colditz GA: Current estimates of the economic cost of obesity in the United States. Obes Res 1998;6:97-106. (Pubitemid 128679649)
6. Hauner H, Landgraf R, Schulze J, Spranger J, Standl E: Nationales Aktionsforum Diabetes mellitus. Prävention des Typ-2-Diabetes mellitus. Positionspapier des Nationalen Aktionsforum Diabetes Mellitus. Dtsch Med Wochenschr 2005;130:1053-1054.
7. Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P, Keinanen-Kiukaanniemi S, Laakso M, Louheranta A, Rastas M, Salminen V, Uusitupa M; Finnish Diabetes Prevention Study Group: Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J I Med 2001;344:1343-1350. (Pubitemid 32378388)
8. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM; Diabetes Prevention Program Research Group: reduction in the incidence of type 2 diabetes with I lifestyle intervention or metformin. N Engl J Med 2002;346:393-403. (Pubitemid 34437694)
9. Chiasson JL, Josse RG, Gomis R, Hanefeld M, Karasik A, Laakso M; STOP-NIDDM Trial Research Group: acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial. Lancet 2002;359:2072-2077. (Pubitemid 34680970)
10. Schulze MB, Hu FB: Primary prevention of diabetes: what can be done and how much can be prevented? Annu Rev Public Health 2005;26:445-467. (Pubitemid 40547392)
11. Schulze MB, Hoffmann K, Boeing H, Linseisen J, Rohrmann S, Möhlig M, Pfeiffer AF, Spranger J, Thamer C, Häring HU, Fritsche A, Joost HG: An accurate risk score based on anthropometric, dietary, and lifestyle factors to predict the development of type 2 diabetes. Diabetes Care 2007;30: 510-515. (Pubitemid 46354326)
12. Kahn BB: Type-2-diabetes: when insulin secretion fails to compensate for insulin resistance. Cell 1998;92:593-596. (Pubitemid 28141507)
13. Plum L, Kluge R, Giesen K, Altmuller J, Ortlepp JR, Joost HG: Type 2 diabetes-like hyperglycaemia in a backcross model of NZO and SJL mice: characterization of a susceptibility locus on chromosome 4 and its relation with obesity. Diabetes 2000; 49:1590-1596.
14. Colditz GA, Willett WC, Rotnitzky A, Manson JE: Weight gain as a risk factor for clinical diabetes mellitus in women. Ann Intern Med 1995;122:481-486.
15. Wang Y, Rimm EB, Stampfer MJ, Willett WC, I Hu FB: Comparison of abdominal adiposity and overall obesity in predicting risk of type 2 diabetes among men. Am J Clin Nutr 2005;81:555-563.
16. Bajaj M, Suraamornkul S, Piper P, Hardies LJ, Glass L, Cersosimo E, Pratipanawatr T, Miyazaki Y, DeFronzo RA: Decreased plasma adiponectin concentrations are closely related to hepatic fat content and hepatic insulin resistance in pioglita-zone-treated type 2 diabetic patients. J Clin Endocrinol Metab 2004;89:200-206. (Pubitemid 38183882)
17. Bajaj M, Suraamornkul S, Pratipanawatr T, Hardies LJ, Pratipanawatr W, Glass L, Cersosimo E, Miyazaki Y, DeFronzo RA: Pioglitazone reduces hepatic fat content and augments splanchnic glucose uptake in patients with type 2 diabetes. Diabetes 2003;52:1364-1370. (Pubitemid 36666189)
18. Stumvoll M: Control of glycaemia: from molecules to men. Minkowski Lecture 2003. Diabetologia 2004;47:770-781. (Pubitemid 38756989)
19. Lan H, Rabaglia ME, Stoehr JP, Nadler ST, Schueler KL, Zou F, Yandell BS, Attie AD: Gene expression profiles of nondiabetic and diabetic obese mice suggest a role of hepatic lipogenic capacity in diabetes susceptibility. Diabetes 2003;52: 688-700. (Pubitemid 36323576)
20. Becker W, Kluge R, Kantner T, Linnartz K, Korn I M, Tschank G, Plum L, Giesen K, Joost HG: Differential hepatic gene expression in a polygenic mouse model with insulin resistance and hyperglycaemia: Evidence for a combined transcriptional dysregula- I tion of gluconeogenesis and fatty acid synthesis. J Mol Endocrinol 2004;32:195-208. (Pubitemid 38312631)
21. Petersen KF, Dufour S, Befroy D, Lehrke M, Hendler RE, Shulman GI: Reversal of nonalcoholic hepatic steatosis, hepatic insulin resistance, and hyperglycaemia by moderate weight reduction in patients with type 2 diabetes. Diabetes 2005;54:603-608. (Pubitemid 40322060)
22. Unger RH: Weapons of lean body mass destruction: the role of ectopic lipids in the metabolic syndrome. Endocrinology 2003;144:5159-5165. (Pubitemid 37476041)
23. Leahy JL: Natural history of beta-cell dysfunction in NIDDM. Diabetes Care 1990;13:992-1010. (Pubitemid 20260737)
24. Brownlee M: A radical explanation for glucose-induced beta cell dysfunction. J Clin Invest 2003; 112:1788-1790. (Pubitemid 38063700)
25. Harmon JS, Stein R, Robertson RP: Oxidative I stress-mediated, post-translational loss of MafA protein as a contributing mechanism to loss of insulin gene expression in glucotoxic beta cells. J Biol Chem 2005;280:11107-11113. (Pubitemid 40418415)
26. Robertson RP, Zhang HJ, Pyzdrowski KL, Walseth TF: Preservation of insulin mRNA levels and insulin secretion in HIT cells by avoidance of chronic exposure to high glucose concentrations. J Clin Invest 1992;90:320-325.
27. Leiter EH, Coleman DL, Eisenstein AB, Strack I: Dietary control of pathogenesis in C57BL/KsJ db/db diabetes mice. Metabolism 1981;30:554-562. (Pubitemid 11116914)
28. Leiter EH, Coleman DL, Ingram DK, Reynolds MA: Influence of dietary carbohydrate on the induction of diabetes in C57BL/KsJ-db/db diabetes mice. J Nutr 1983;113:184-195. (Pubitemid 13130663)
29. Jürgens H, Schmolz K, Neschen S, Ortmann S, Blüher M, Klaus S, Tschöp M, Joost HG, Schürmann A: Development of diabetes in morbidly obese New-Zealand Obese (NZO) mice requires dietary carbohydrates: Evidence for an essential role of glucose toxicity in β-cell destruction. Dia-betologia 2006;50:1481-1489.
30. Poitout V, Robertson RP: Minireview: Secondary beta-cell failure in type 2 diabetes - a convergence of glucotoxicity and lipotoxicity. Endocrinology 2002;143:339-342. (Pubitemid 34107184)
31. Spranger J, Kroke A, Möhlig M, Bergmann MM, Ristow M, Boeing H, Pfeiffer AF: Adiponectin and protection against type 2 diabetes mellitus. Lancet 2003;361:226-228. (Pubitemid 36126226)
32. Kolb H, Mandrup-Poulsen T: An immune origin of type 2 diabetes? Diabetologia 2005;48:1038-1050. (Pubitemid 40909636)
33. Sjoholm A, Nystrom T Inflammation and the etiology of type 2 diabetes. Diabetes Metab Res Rev 2006;22:4-10.
34. Leiter EH, Reifsnyder PC, Flurkey K, Partke HJ, Junger E, Herberg L: NIDDM genes in mice: deleterious synergism by both parental genomes contributes to diabetogenic thresholds. Diabetes 1998; 47:1287-1295. (Pubitemid 28357007)
35. Plum L, Giesen K, Kluge R, Junger E, Linnartz K, Schurmann A, Becker W, Joost HG: Characterisation of the mouse diabetes susceptibilty locus Nidd/SJL: islet cell destruction, interaction with the obesity QTL Nob1, and effect of dietary fat. Dia-betologia 2002;45:823-830.
36. Clee SM, Yandell BS, Schueler KM, Rabaglia ME, Richards OC, Raines SM, Kabara EA, Klass DM, Mui ET, Stapleton DS, Gray-Keller MP, Young MB, Stoehr JP, Lan H, Boronenkov I, Raess PW, Flowers MT, Attie AD: Positional cloning of Sorcs1, a type 2 diabetes quantitative trait locus. Nat Genet 2006;38:688-693. (Pubitemid 43927312)
37. Medici F, Hawa M, Ianari A, Pyke DA, Leslie RD. Concordance rate for type II diabetes mellitus in monozygotic twins: actuarial analysis. Diabetologia 1999;42:146-150. (Pubitemid 29064235)
38. Hansen L, Pedersen O: Genetics of type 2 diabetes mellitus: status and perspectives. Diabetes Obesity Metab 2005;7:122-135. (Pubitemid 40352727)
39. Stevenson C, Barroso I, Wareham N: The genetics of type 2 diabetes; in Brigelius-Flohé R, Joost HG (eds): Nutritional Genomics. Weinheim, Wiley-VCH, 2006, pp 223-265.
40. Horikawa Y, Oda N, Cox NJ, Li X, Orho-Melander M, Hara M, Hinokio Y, Lindner TH, Mashima H, Schwarz PE, del Bosque-Plata L, Horikawa Y, Oda Y, Yoshiuchi I, Colilla S, Polonsky KS, Wei S, Concannon P, Iwasaki N, Schulze J, Baier LJ, Bogardus C, Groop L, Boerwinkle E, Hanis CL, Bell GI: Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus. Nat Genet 2000;26:163-175.
41. Grant SF, Thorleifsson G, Reynisdottir I, Bene -diktsson R, Manolescu A, Sainz J, Helgason A, Stefansson H, Emilsson V, Helgadottir A, Styrkars-dottir U, Magnusson KP, Walters GB, Palsdottir E, Jonsdottir T, Gudmundsdottir T, Gylfason A, Saemundsdottir J, Wilensky RL, Reilly MP, Rader DJ, Bagger Y, Christiansen C, Gudnason V, Sigurdsson G, Thorsteinsdottir U, Gulcher JR, Kong A, Stefansson K: Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nat Genet 2006;38:320-323.
42. Cauchi S, El Achhab Y, Choquet H, Dina C, Krempler F, Weitgasser R, Nejjari C, Patsch W, Chikri M, Meyre D, Froguel P: TCF7L2 is repro-ducibly associated with type 2 diabetes in various ethnic groups: a global meta-analysis. J Mol Med 2007;85:777-782. (Pubitemid 47063530)
43. Guo T, Hanson RL, Traurig M, Muller YL, Ma L, Mack J, Kobes S, Knowler WC, Bogardus C, Baier LJ: TCF7L2 is not a major susceptibility gene for type 2 diabetes in Pima Indians: analysis of 3,501 individuals. Diabetes 2007;56:3082-3088. (Pubitemid 350223645)
44. Song Y, Niu T, Manson JE, Kwiatkowski DJ, Liu S: Are variants in the CAPN10 gene related to risk of type 2 diabetes? A quantitative assessment of population and family-based association studies. Am J Hum Genet 2004;74:208-222. (Pubitemid 38168609)
45. Barroso I, Luan J, Middelberg RP, Harding AH, Franks PW, Jakes RW, Clayton D, Schafer AJ, O'Rahilly S, Wareham NJ: Candidate gene association study in type 2 diabetes indicates a role for genes involved in beta-cell function as well as insulin action. PLoS Biol 2003;1:E20.
46. Sladek R, Rocheleau G, Rung J, Dina C, Shen L, Serre D, Boutin P, Vincent D, Belisle A, Hadjadj S, Balkau B, Heude B, Charpentier G, Hudson TJ, Montpetit A, Pshezhetsky AV, Prentki M, Posner BI, Balding DJ, Meyre D, Polychronakos C, Froguel P: A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature 2007;445: 881-885.
47. Scott LJ, Mohlke KL, Bonnycastle LL, Willer CJ, Li Y, Duren WL, Erdos MR, Stringham HM, Chines PS, Jackson AU, Prokunina-Olsson L, Ding CJ, Swift AJ, Narisu N, Hu T, Pruim R, Xiao R, Li XY, Conneely KN, Riebow NL, Sprau AG, Tong M, White PP, Hetrick KN, Barnhart MW, Bark CW, Goldstein JL, Watkins L, Xiang F, Saramies J, Buchanan TA, Watanabe RM, Valle TT, Kinnunen L, Abecasis GR, Pugh EW, Doheny KF, Bergman RN, Tuomilehto J, Collins FS, Boehnke M: A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science 2007;316:1341-1345. (Pubitemid 46871655)
48. Steinthorsdottir V, Thorleifsson G, Reynisdottir I, Benediktsson R, Jonsdottir T, Walters GB, Styr -karsdottir U, Gretarsdottir S, Emilsson V, Ghosh S, Baker A, Snorradottir S, Bjarnason H, Ng MC, Hansen T, Bagger Y, Wilensky RL, Reilly MP, Adeyemo A, Chen Y, Zhou J, Gudnason V, Chen G, Huang H, Lashley K, Doumatey A, So WY, Ma RC, Andersen G, Borch-Johnsen K, Jorgensen T, van Vliet-Ostaptchouk JV, Hofker MH, Wijmenga C, Christiansen C, Rader DJ, Rotimi C, Gurney M, Chan JC, Pedersen O, Sigurdsson G, Gulcher JR, Thorsteinsdottir U, Kong A, Stefansson K: A variant in CDKAL1 influences insulin response and risk of type 2 diabetes. Nat Genet 2007;39:770-775. (Pubitemid 46848592)
49. Saxena R, Voight BF, Lyssenko V, Burtt NP, de Bakker PI, Chen H, Roix JJ, Kathiresan S, Hirschhorn JN, Daly MJ, Hughes TE, Groop L, Alt-shuler D, Almgren P, Florez JC, Meyer J, Ardlie K, Bengtsson Boström K, Isomaa B, Lettre G, Lind-blad U, Lyon HN, Melander O, Newton-Cheh C, Nilsson P, Orho-Melander M, Råstam L, Speliotes EK, Taskinen MR, Tuomi T, Guiducci C, Berglund A, Carlson J, Gianniny L, Hackett R, Hall L, Holmkvist J, Laurila E, Sjögren M, Sterner M, Surti A, Svensson M, Svensson M, Tewhey R, Blumenstiel B, Parkin M, Defelice M, Barry R, Brodeur W, Camarata J, Chia N, Fava M, Gibbons J, Handsaker B, Healy C, Nguyen K, Gates C, Sougnez C, Gage D, Nizzari M, Gabriel SB, Chirn GW, Ma Q, Parikh H, Richardson D, Ricke D, Purcell S: Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science 2007;316:1331-1336. (Pubitemid 46871653)
50. Sandhu MS, Weedon MN, Fawcett KA, Wasson J, Debenham SL, Daly A, Lango H, Frayling TM, Neumann RJ, Sherva R, Blech I, Pharoah PD, Palmer CN, Kimber C, Tavendale R, Morris AD, McCarthy MI, Walker M, Hitman G, Glaser B, Permutt MA, Hattersley AT, Wareham NJ, Barroso I: Common variants in WFS1 confer risk of type 2 diabetes. Nat Genet 2007;39:951-953. (Pubitemid 47185173)
51. Florez JC, Manning AK, Dupuis J, McAteer J, Irenze K, Gianniny L, Mirel DB, Fox CS, Cupples LA, Meigs JB: A 100K genome-wide association scan for diabetes and related traits in the Framingham Heart Study: replication and integration with other genome-wide datasets. Diabetes 2007;56:3063-3074. (Pubitemid 350223643)
52. Hanson RL, Bogardus C, Duggan D, Kobes S, Knowlton M, Infante AM, Marovich L, Benitez D, Baier LJ, Knowler WC: A search for variants associated with young-onset type 2 diabetes in American Indians in a 100K genotyping array. Diabetes 2007;56:3045-3052. (Pubitemid 350223641)
53. Aulchenko YS, Pullen J, Kloosterman WP, Yazdan-panah M, Hofman A, Vaessen N, Snijders PJ, Zubakov D, Mackay I, Olavesen M, Sidhu B, Smith VE, Carey A, Berezikov E, Uitterlinden AG, Plas-terk RH, Oostra BA, van Duijn CM: LPIN2 is associated with type 2 diabetes, glucose metabolism, and body composition. Diabetes 2007;56:3020-3026. (Pubitemid 350223638)
54. Rampersaud E, Damcott CM, Fu M, Shen H, McArdle P, Shi X, Shelton J, Yin J, Chang YP, Ott SH, Zhang L, Zhao Y, Mitchell BD, O'Connell J, Shuldiner AR: Identification of novel candidate genes for type 2 diabetes from a genome-wide association scan in the Old Order Amish: evidence for replication from diabetes-related quantitative traits and from independent populations. Diabetes 2007; 56:3053-3062. (Pubitemid 350223642)
55. Hayes MG, Pluzhnikov A, Miyake K, Sun Y, Ng MC, Roe CA, Below JE, Nicolae RI, Konkashbaev A, Bell GI, Cox NJ, Hanis CL: Identification of type 2 diabetes genes in Mexican Americans through genome-wide association studies. Diabetes 2007;56: 3033-3044. (Pubitemid 350223640)
56. West DB, Boozer CN, Moody DL, Atkinson RL: Dietary obesity in nine inbred mouse strains. Am J Physiol 1992;262:R1025-1032.
57. Hu FB, Manson JE, Stampfer MJ, Colditz G, Liu S, Solomon CG, Willett WC: Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. N Engl J Med 2001;345:790-797.
58. Willett W, Manson J, Liu S: Glycemic index, gly cemic load, and risk of type 2 diabetes. Am J Clin Nutr 2002;76:274S-280S. (Pubitemid 34686580)
59. Schulze MB, Manson JE, Ludwig DS, Colditz GA, Stampfer MJ, Willett WC, Hu FB: Sugar-sweetened beverages, weight gain, and incidence of type 2 diabetes in young and middle-aged women. JAMA 2004;292:927-934. (Pubitemid 39097202)
60. Schulze MB, Schulz M, Heidemann C, Schien -kiewitz A, Hoffmann K, Boeing H: Fiber and magnesium intake and incidence of type 2 diabetes: a prospective study and meta-analysis. Arch Intern Med 2007;167:956-965. (Pubitemid 46762759)
61. Heidemann C, Hoffmann K, Spranger J, Klipstein-Grobusch K, Mohlig M, Pfeiffer AF, Boeing H: A dietary pattern protective against type 2 diabetes in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study cohort. Diabetologia 2005;48:1126-1134. (Pubitemid 40909648)
62. van Dam RM, Rimm EB, Willett WC, Stampfer MJ, Hu FB: Dietary patterns and risk for type 2 diabetes mellitus in U.S. men. Ann Intern Med 2002; 136:201-209. (Pubitemid 34118120)
63. Hoffmann K, Schulze MB, Schienkiewitz A, Noth-lings U, Boeing H: Application of a new statistical method to derive dietary patterns in nutritional epidemiology. Am J Epidemiol 2004;159:935-944. (Pubitemid 38608270)
64. Montonen J, Knekt P, Harkanen T, Jarvinen R, Heliovaara M, Aromaa A, Reunanen A: Dietary patterns and the incidence of type 2 diabetes. Am J Epidemiol 2005;161:219-227. (Pubitemid 40223510)
65. Sigal RJ, Kenny GP, Wasserman DH, Castaneda-Sceppa C: Physical activity/exercise and type 2 diabetes. Diabetes Care 2004;27:2518-2539. (Pubitemid 39281418)
66. Hu FB, Leitzmann MF, Stampfer MJ, Colditz GA, Willett WC, Rimm EB: Physical activity and television watching in relation to risk for type 2 diabetes mellitus in men. Arch Intern Med. 2001;161:1542-1548. (Pubitemid 32679568)
67. Hawley JA: Exercise as a therapeutic intervention for the prevention and treatment of insulin resistance. Diabetes Metab Res Rev 2004;20:383-393. (Pubitemid 39302963)
68. Sargeant LA, Khaw KT, Bingham S, Day NE, Luben RN, Oakes S, Welch A, Wareham NJ: Cigarette smoking and glycaemia: the EPIC-Norfolk Study. European Prospective Investigation into Cancer. Int J Epidemiol 2001;30:547-554. (Pubitemid 32600248)
69. Stern MP, Williams K, Haffner SM: Identification of persons at high risk for type 2 diabetes mellitus: do we need the oral glucose tolerance test? Ann Intern Med 2002;136:575-581. (Pubitemid 34407041)
70. Lindstrom J, Tuomilehto J: The diabetes risk score: a practical tool to predict type 2 diabetes risk. Diabetes Care 2003;26:725-731. (Pubitemid 36929335)
71. McNeely MJ, Boyko EJ, Leonetti DL, Kahn SE, Fujimoto WY: Comparison of a clinical model, the oral glucose tolerance test, and fasting glucose for prediction of type 2 diabetes risk in Japanese Americans. Diabetes Care 2003;26:758-763. (Pubitemid 36929340)
72. Schmidt MI, Duncan BB, Bang H, Pankow JS, Bal-lantyne CM, Golden SH, Folsom AR, Chambless LE: Identifying individuals at high risk for diabetes: the Atherosclerosis Risk in Communities study Diabetes Care 2005;28:2013-2018. (Pubitemid 41060977)
73. Kanaya AM, Fyr CL, de Rekeneire N, Shorr RI, Schwartz AV, Goodpaster BH, Newman AB, Harris T, Barrett-Connor E: Predicting the development of diabetes in older adults: the derivation and validation of a prediction rule. Diabetes Care 2005;28: 404-408. (Pubitemid 40170947)
74. Norberg M, Eriksson JW, Lindahl B, Andersson C, Rolandsson O, Stenlund H, Weinehall L: A combination of HbA1c, fasting glucose and BMI is effective in screening for individuals at risk of future type 2 diabetes: OGTT is not needed. J Intern Med 2006;260:263-271. (Pubitemid 44253640)
75. Rathmann W, Martin S, Haastert B, Icks A, Holle R, Lowel H, Giani G; KORA Study Group: Performance of screening questionnaires and risk scores for undiagnosed diabetes: the KORA Survey 2000. Arch Intern Med 2005;165:436-441. (Pubitemid 40280200)
76. Schulze MB, Boeing H, Fritsche A, Häring HU, Joost HG: Validation of the German Diabetes Risk Score (DRS) with metabolic risk factors for type 2 diabetes (in German). Dtsch Med Wochenschr 2008;133: 878-883. (Pubitemid 351828503)
77. Tirosh A, Shai I, Tekes-Manova D, Israeli E, Pereg D, Shochat T, Kochba I, Rudich A; Israeli Diabetes Research Group: Normal fasting plasma glucose levels and type 2 diabetes in young men. N Engl J Med 2005;353:1454-1462. (Pubitemid 41400919)
78. Khaw KT, Wareham N, Luben R, Bingham S, Oakes S, Welch A, Day N: Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of european prospective investigation of cancer and nutrition (EPIC-Norfolk) BMJ 2001;322:15-18. (Pubitemid 32066250)
79. Lyssenko V, Almgren P, Anevski D, Perfekt R, Lahti K, Nissen M, Isomaa B, Forsen B, Homstrom N, Saloranta C, Taskinen MR, Groop L, Tuomi T; Botnia study group: Predictors of and longitudinal changes in insulin sensitivity and secretion pre ceding onset of type 2 diabetes. Diabetes 2005;54: 166-174. (Pubitemid 40105109)
80. Perry IJ, Wannamethee SG, Shaper AG: Prospective study of serum gamma-glutamyltransferase and risk of NIDDM. Diabetes Care 1998;21:732-737. (Pubitemid 28487063)
81. Herder C, Baumert J, Thorand B, Koenig W, de Jager W, Meisinger C, Illig T, Martin S, Kolb H: Chemokines as risk factors for type 2 diabetes: results from the MONICA/KORA Augsburg study, 1984-2002. Diabetologia 2006;49:921-929.
82. Spranger J, Kroke A, Mohlig M, Hoffmann K, Bergmann MM, Ristow M, Boeing H, Pfeiffer AF Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. Diabetes 2003;52:812-817. (Pubitemid 36323590)
83. Trujillo ME, Scherer PE: Adiponectin - journey from an adipocyte secretory protein to biomarker of the metabolic syndrome. J Intern Med 2005;257: 167-175. (Pubitemid 40193966)
84. Torgerson JS, Hauptman J, Boldrin MN, Sjostrom L: XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care 2004;27:155-161. (Pubitemid 38196725)
85. Sugerman HJ, Wolfe LG, Sica DA, Clore JN: Diabetes and hypertension in severe obesity and effects of gastric bypass-induced weight loss. Ann Surg 2003;237:751-756.
86. Costa A, Conget I, Gomis R: Impaired glucose tolerance: is there a case for pharmacologic intervention? Treat Endocrinol 2002;1:205-210. (Pubitemid 36828413)
87. Vessby B, Unsitupa M, Hermansen K, Riccardi G, Rivellese AA, Tapsell LC, Nälsén C, Berglund L, Louheranta A, Rasmussen BM, Calvert GD, Maffetone A, Pedersen E, Gustafsson IB, Storlien LH; KANWU Study: Substituting dietary saturated for monounsaturated fat impairs insulin sensitivity in healthy men and women: The KANWU Study. Diabetologia 2001;44:312-319. (Pubitemid 32234457)
88. Yusuf S, Gerstein H, Hoogwerf B, Pogue J, Bosch J, Wolffenbuttel BH, Zinman B; HOPE Study Investigators: Ramipril and the development of diabetes. JAMA 2001;286:1882-1885. (Pubitemid 33010241)
89. Scheen AJ: Prevention of type 2 diabetes mellitus through inhibition of the renin-angiotensin system. Drugs 2004;64:2537-2565. (Pubitemid 39591650)
90. Thamer C, Machann J, Stefan N, Haap M, Schäfer S, Brenner S, Kantartzis K, Claussen C, Schick F, Haring H, Fritsche A: High visceral fat mass and high liver fat are associated with resistance to lifestyle intervention. Obesity 2007;15:531-538. (Pubitemid 46407335)
91. Weyrich P, Stefan N, Häring HU, Laakso M, Fritsche A: Effect of genotype on success of lifestyle intervention in subjects at risk for type 2 diabetes. J Mol Med 2007;85:107-117. (Pubitemid 46183610)
92. Fisher E, Boeing H, Hoffmann K, Fritsche A, Doer-ing F, Joost HG, Schulze MB: Whole-grain bread consumption and TCF7L2 rs7903146: Gene-environment interaction in modulating type 2 diabetes risk. Br J Nutr 2008; (in press).